Erosive oral lichen planus after pegylated-interferon therapy for chronic hepatitis B

Friedrich, 2003, Oral lichen planus in patients with chronic liver diseases, Infection, 31, 383, 10.1007/s15010-003-4074-5

Maticic, 2008, Lichen planus and other cutaneous manifestations in chronic hepatitis C: pre- and post-interferon-based treatment prevalence vary in a cohort of patients from low hepatitis C virus endemic area, J Eur Acad Dermatol Venereol, 22, 779, 10.1111/j.1468-3083.2008.02676.x

Remmerbach, 2016, No association of oral lichen planus and hepatitis C virus infection in central Germany, Clin Oral Investig, 20, 193, 10.1007/s00784-015-1602-5

Grigorescu, 2014, Spontaneous and antiviral-induced cutaneous lesions in chronic hepatitis B virus infection, World J Gastroenterol, 20, 15860, 10.3748/wjg.v20.i42.15860

Dalekos, 1998, A prospective evaluation of dermatological side-effects during alpha-interferon therapy for chronic viral hepatitis, Eur J Gastroenterol Hepatol, 10, 933, 10.1097/00042737-199811000-00006

Patrk, 2014, Cutaneous reactions in patients with chronic hepatitis C treated with peginterferon and ribavirin, Dermatology, 228, 42, 10.1159/000353160

Kaya, 2015, Lichen planus induced by pegylated interferon alfa-2a therapy in a patient monitored for delta hepatitis, Case Rep Infect Dis, 2015, 389131

Pinto, 2003, Lichen planus and leukocytoclastic vasculitis induced by interferon alpha-2b in a subject with HCV-related chronic active hepatitis, J Eur Acad Dermatol Venereol, 17, 193, 10.1046/j.1468-3083.2003.00583.x

Jadali, 2012, Dermatologic manifestations of hepatitis C infection and the effect of interferon therapy: a literature review, Arch Iran Med, 15, 43

Higuchi, 2002, Epidemiology and clinical aspects on hepatitis C, Jpn J Infect Dis, 55, 69